Home › NDC Lookup › RxCUI directory › RxCUI 207273

Nitroglycerin 0.02 MG/MG Topical Ointment [Nitro-Bid] — RxCUI 207273

Name: Nitroglycerin 0.02 MG/MG Topical Ointment [Nitro-Bid] (RxCUI 207273)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 207273 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI207273

Official nameNitroglycerin 0.02 MG/MG Topical Ointment [Nitro-Bid]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asNitro-Bid 2 % Topical Ointment; Nitro-Bid 0.02 MG/MG Topical Ointment; Nitro-Bid 20 MG/GM Topical Ointment; NTG 0.02 MG/MG Topical Ointment [Nitro-Bid]; TNG 0.02 MG/MG Topical Ointment [Nitro-Bid]

FDA products mapped1

Package NDCs mapped3

Reported Medicaid activity (SDUD)8,740 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nitroglycerin Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

No — the nitroglycerin patch works too slowly for that. It's designed to prevent angina from happening in the first place, not to stop an attack once it starts. You should still ha...
Can I use this patch to stop chest pain that's already started?
Yes, the nightly break is essential. Wearing the patch around the clock causes your body to stop responding to it — this is called tolerance — and the patch can completely lose its...
Do I really have to take the patch off every night? What happens if I just leave it on?

📖 Read our full Nitroglycerin Transdermal Patch guide →

🕸️ Concept Web — How Nitroglycerin 0.02 MG/MG Topical Ointment [Nitro... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Nitroglycerin 0.02 MG/MG Topical Ointment [Nitro-Bid] RxCUI 207273 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Nitroglycerin 4917 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Nitro-Bid 202516 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Nitroglycerin Topical Ointment 374405 SCDF
- Nitroglycerin Topical Product 1159832 SCDG
- Nitroglycerin Topical Ointment [Nitro-Bid] 93485 SBDF
- Nitro-Bid Topical Product 1183932 SBDG
- Topical Ointment 316985 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Nitroglycerin 0.02 MG/MG Topical Ointment 242946 SCD
- Nitroglycerin 0.02 MG/MG 328468 SCDC
- Nitroglycerin 0.02 MG/MG [Nitro-Bid] 568058 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Nitroglycerin 0.02 MG/MG Topical Ointment SCD · 242946
Nitroglycerin 0.02 MG/MG SCDC · 328468
Nitroglycerin Topical Ointment SCDF · 374405
Nitroglycerin Topical Product SCDG · 1159832

Brand-Name Concepts

Nitroglycerin 0.02 MG/MG [Nitro-Bid] SBDC · 568058
Nitroglycerin Topical Ointment [Nitro-Bid] SBDF · 93485
Nitro-Bid Topical Product SBDG · 1183932
Nitro-Bid BN · 202516

📦 FDA Products & Package NDCs

1 product · 3 package NDCs

3 package NDCs map to RxCUI 207273 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00281-0326-08	48 PACKET in 1 BOX (0281-0326-08) / 1 g in 1 PACKET	NITRO-BID	Savage Laboratories a division of Fougera Pharmaceuticals, LLC	2009-08-17
00281-0326-30	30 g in 1 TUBE (0281-0326-30)	NITRO-BID	Savage Laboratories a division of Fougera Pharmaceuticals, LLC	2009-08-17
00281-0326-60	60 g in 1 TUBE (0281-0326-60)	NITRO-BID	Savage Laboratories a division of Fougera Pharmaceuticals, LLC	2009-08-17

Observed labelers: Savage Laboratories a division of Fougera Pharmaceuticals, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per gm · median

$1.2335

Range $1.2270–$2.4219 · middle 50% $1.2302–$1.8277 · 3 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.